That's where investors in ADN have an edge. Very-high IRR (i.e. low capital intensity) means the probability of dilution is significantly reduced.
ADN aren't like HPA and Lithium projects that have combined CAPEX and working capital burdens in excess of $200M.
Ann: Appendix 2A - Exercise of Options, page-12
Add ADN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
-0.001(7.69%) |
Mkt cap ! $20.57M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.7¢ | 0.6¢ | $26.59K | 4.398M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 8106342 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 8773977 | 21 |
View Market Depth
| Last trade - 15.58pm 08/11/2024 (20 minute delay) ? |
| ADN (ASX) Chart |